Pharmaceutical Product Development PPDI
-
New Morningstar Analyst Report - Parexel International Corporation
… infrastructure that enables it to compete for complex global trials against larger rivals such as Quintiles and Pharmaceutical Product Development . Parexel also offers consulting and medical communication services to assist clients throughout all …
-
New Morningstar Analyst Report - ICON PLC
… competes with several larger and more established rivals in the CRO industry, such as Covance and Pharmaceutical Product Development , which boast greater capital resources and staffing capabilities.We expect the cost advantages …
-
Diamond Hill Small-Mid Cap Fund Fourth Quarter Commentary
… and development services provider Pharmaceutical Product Development , Inc. was taken private during ..... During the quarter, our position in Pharmaceutical Product Development , Inc. was eliminated as two private …
-
Diamond Hill Long-Short Fund Fourth Quarter Commentary
… saturation. Eliminated Positions We eliminated our long positions in Pharmaceutical Product Development , Inc. and KLA-Tencor Corp. Pharmaceutical Product Development was acquired by two private equity firms while KLA-Tencor was eliminated …
-
Diamond Hill Research Opportunities Fund Fourth Quarter Commentary
… Advent Software, Inc. Eliminated Positions We eliminated our long positions in Assurant, Inc. , Pharmaceutical Product Development , Inc. , Bristol-Myers Squibb Co. , Wal-Mart Stores, Inc. , National Penn Bancshares, Inc …
-
CROs Will Return to Relevance in 2012
… widespread top-line growth. Covance CVD and Pharmaceutical Product Development PPDI were once again the biggest top-line ..... efforts. The acquisition of leading CRO Pharmaceutical Product Development (by private equity groups Carlyle Group …
-
Wall Street Breakfast: Must-Know News
… SPLS]], [[TJX]], [[WMT]] Notable earnings after Tuesday's close: [[A]], [[ADSK]], [[DELL]], [[ PPDI ]] Get Wall Street Breakfast by email -- it's free and takes only seconds to sign up. Complete Story »
-
Notable earnings after Tuesday's close: [[A]], [[ADSK]], [[DELL]], [[ PPDI ]]
Notable earnings after Tuesday's close: A , ADSK , DELL , PPDI Post your comment!
-
Furiex Pharmaceuticals Breaks Downtrend As Insiders Buy In Big
By M.E. Garza : Shares of Furiex Pharmaceuticals, Inc.( FURX ) have just moved past some resistance at the 200 day moving average following some heavy insider buying and ahead of some clinical trial results. Furiex' product pipeline includes: Priligy® (dapoxetine) is a drug specifically developed
-
LPC-PPD to launch $1.325 bln buyout loan to retail syndication
NEW YORK, Nov 4 (LPC) - Pharmaceutical Product Development (PPD) is launching on November 8 at 10 a.m. the retail syndication of its buyout loan, sources said.